• Protease Inhibitor Cocktail: Optimizing Lipid Droplet Analys

  2026-07-03

  The Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) from APExBIO is engineered for exceptional protein stability in complex cell and tissue extracts, making it indispensable for lipid droplet metabolism studies. Discover how its broad-spectrum inhibition, water solubility, and workflow flexibility empower reproducibility in DFCP1-ATGL research and high-sensitivity proteomics.

• Protease Inhibitor Cocktail EDTA-Free: Precision in Protein

  2026-07-03

  Unlock artifact-free, phosphorylation-compatible protein extraction with the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO). This guide translates recent breakthroughs in mitocytosis-targeted therapy into actionable protocols, troubleshooting, and advanced applications for APExBIO’s robust inhibitor blend.

• Lysis Buffer Innovation: Enhancing Mouse Genotyping Precisio

  2026-07-02

  Explore how the lysis buffer, a rapid genotyping kit component, advances genomic DNA release from mouse tail samples. This article delivers new insights into workflow optimization and translational research applications.

• (1S,3R)-RSL3: Next-Gen Ferroptosis Inducer for GPX4-Driven O

  2026-07-02

  (1S,3R)-RSL3 is a potent glutathione peroxidase 4 inhibitor advancing ferroptosis research in cancer biology. This article uniquely explores how RSL3 integrates with radiosensitization strategies and redox modulation, offering new perspectives beyond standard apoptotic approaches.

• Species-Specific Pharmacokinetics of HD56: Insights from Hum

  2026-07-01

  This study establishes humanized liver mice as a robust model for evaluating the pharmacokinetics and metabolism of carboxylate ester prodrugs such as HD56, highlighting notable species differences and a strong in vivo-in vitro correlation. The findings offer a predictive framework for prodrug research and underscore the necessity of species-appropriate models in translational drug development.

• Salvianolic Acid B: Mechanistic Evidence for Antifibrotic Ac

  2026-07-01

  Salvianolic acid B is a polyphenolic compound with verified antifibrotic activity through inhibition of lysyl hydroxylase 2 (LH2), leading to reduced collagen synthesis in pulmonary fibrosis models. Its well-characterized solubility and purity profile support broad research utility as a benchmark extracellular matrix remodeling agent.

• TG003 Cdc2-like Kinase Inhibitor: Optimizing Splicing Assays

  2026-06-30

  TG003 enables precise, reproducible modulation of alternative splicing and platinum resistance pathways, making it indispensable for both basic and translational research. This guide bridges evidence-based protocols with troubleshooting and innovative use-cases to empower RNA and cancer researchers.

• Protease Inhibitor Cocktail (MS-SAFE): Next-Gen Protein Inte

  2026-06-30

  Discover how the Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) revolutionizes protein degradation prevention in advanced proteomics. This article explores its mechanistic depth, MS compatibility, and the latest viral protein insights for researchers seeking robust assay performance.

• Protease Inhibitor Cocktail (100X H₂O, EDTA Plus): Safeguard

  2026-06-29

  Discover how the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) empowers high-fidelity protein extraction for advanced lipid droplet metabolism studies. Explore its mechanistic advantages, unique role in preserving labile complexes, and practical guidance for optimizing proteomic workflows.

• MTT Assays in Angiogenesis: Advanced Insights and Protocols

  2026-06-29

  Explore the advanced scientific underpinnings of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) in in vitro angiogenesis and cell viability research. This article uniquely connects contemporary mechanistic evidence with practical assay optimization, surpassing generic guides for deeper experimental clarity.

• In Vivo and In Vitro Antibacterial Efficacy of Hexetidine Ri

  2026-06-28

  This article analyzes the comparative antibacterial activity of Hexetidine (NSC-17764) and related cationic antiseptics in oral health, based on a landmark study assessing their minimum inhibitory concentrations and residual effects in saliva. The findings highlight Hexetidine's practical strengths and limitations for dental biofilm and infection research.

• Protease and Phosphatase Inhibitor Cocktail: Precision in Pr

  2026-06-27

  Unlock uncompromised protein and phosphoprotein integrity with the Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O). This advanced reagent from APExBIO empowers researchers to execute rigorous protein extraction and cell signaling workflows, with proven performance across diverse biological matrices and compatibility with metal-dependent assays.

• Exo1: Precision Tool for Membrane Trafficking Inhibition

  2026-06-26

  Exo1 (methyl 2-(4-fluorobenzamido)benzoate) delivers acute, selective inhibition of Golgi-to-ER membrane trafficking, uniquely sparing the trans-Golgi network and enabling mechanistic dissection of exocytic processes. Its distinct ARF1 release profile empowers advanced exocytosis and extracellular vesicle research, addressing critical needs in preclinical oncology workflows.

• Angiotensin I (human, mouse, rat): Precision Tools for Next-

  2026-06-26

  Explore the advanced scientific utility of Angiotensin I (human, mouse, rat) in renin-angiotensin system research. This article uniquely examines its molecular mechanism, technical handling, and the latest assay innovations for cardiovascular and neuroendocrine studies.

• USP7 Controls Macrophage Polarization via PKM2 in Severe Pan

  2026-06-25

  This study reveals how ubiquitin-specific protease 7 (USP7) drives inflammatory macrophage polarization in severe acute pancreatitis by modulating PKM2-dependent metabolic reprogramming. These findings highlight the metabolic underpinnings of immune regulation in pancreatitis and point to PKM2 as a potential therapeutic target.

16761 records 1/1118 page Next 12345 下5页 Last page